logo
Sign in

AVCT Stock Price, Chart, Stats & News

Avacta Group Plc
Save

Avacta Group Plc (AVCT) does not currently pay a dividend.

324.14M
Market cap
Current P/E
113.64x
Forward P/E

AVCT chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Avacta Group Plc operates as a clinical-stage biopharmaceutical company, specializing in the development of cancer therapies and diagnostic solutions. These advancements are driven by its proprietary Affimer and pre CISION technology platforms, with the company's activities spanning the United Kingdom, North America, South Korea, and broader regions of Asia and Europe.

Similar securities

Based on sector and market capitalization

Report issue